Le Lézard
Classified in: Health, Business
Subjects: HSP, CXP, DEI

Zuniga Health continues growth, expanding into California, Nevada, New Mexico, Arizona and Colorado to bring affordable health benefits to Hispanic community


MIAMI, Sept. 18, 2023 /PRNewswire/ -- Zuniga Health LLC, an analytics-driven health plan today announced its expansion into states with large Hispanic population: California, Nevada, New Mexico, Arizona and Colorado. The growth adds to the health plan's already existing markets in Illinois, Florida and Texas. Zuniga Health is the first health plan to address the Hispanic market, with premiums typically 15-20% lower than fully-insured carriers.

Zuniga Health amplifies its mission to increase the number of Hispanic employees obtaining affordable health benefits

With its expansion into California, Nevada, New Mexico, Arizona and Colorado during National Hispanic Heritage month, Zuniga Health amplifies its mission to increase the number of Hispanic employees obtaining cost-effective health benefits. California, Florida, Texas and New Mexico are at the core of Hispanic entrepreneurship in the US. California alone is home to 73,000 Hispanic-owned businesses, of which 97% are small businesses.

"I created Zuniga Health to disrupt the existing landscape of the big insurers who raise their premiums annually by double digits for small businesses," said Arthur Vera, Founder and CEO of Zuniga Health. "We are democratizing care, bringing concierge service to SMB's employees in these new states, all while providing the employer with the option to receive a refund of 100% of their claim fund surplus in our level-funded model. Our model is unique, and we are very happy to make our services available to thousands more businesses and brokers and millions more members in the southwest."

Zuniga Health's innovative plans are designed specifically for small- to medium-sized businesses. Plan options are filled with free basic care benefits. The goal is to encourage Hispanic employees to take control of their health in the easiest way possible. All services are offered in English and Spanish.

Basic care with zero co-pay: Zuniga Health's plans offer free generic drugs, free PCP visits, free labs, and free diagnostic imaging.

Unlimited telehealth and telepsychology visits: while other insurance companies charge after two free visits, Zuniga Health members get unlimited telehealth and telepsychology visits.

Premier provider network: employees get access to the largest networks in the country. Choosing their preferred doctors and hospitals is easy.

Concierge approach: members and providers have ONE phone number to call for questions regarding their health benefits, billing, provider search, etc.

CONTACT:
Sonja Reians
[email protected]

SOURCE Zuniga Health


These press releases may also interest you

at 06:37
San Francisco area-based Life360, Inc. ("Life360" or the "Company") today announced the launch of its initial public offering in the U.S. (the "Offering") of 5,750,000 shares of its common stock. Life360 is offering 3,286,231 shares of common stock...

at 06:35
KalVista Pharmaceuticals, Inc. , today announced that it presented real-world data from US patient surveys that assessed the experience of HAE patients using injectable on-demand treatments at the European Academy of Allergy and Clinical Immunology...

at 06:35
DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN's mechanistically relevant iPSC...

at 06:35
Edwards Lifesciences today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) , in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no...

at 06:30
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands BD's portfolio of smart connected care solutions...

at 06:05
Zura Bio Limited ("Zura Bio"), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced it will present data from its tibulizumab (ZB-106) program exploring the clinical...



News published on and distributed by: